New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


Which pharmaceutical drugs have the most drug patents in Norway?

This chart shows the drugs with the most patents in Norway. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in No…


Re-Thinking Management Strategies for Specialty Drug Cost Containment

A 2016 report by the Kaiser Family Foundation reported that approximately one-quarter of the people in the United States have difficulty affording their medications. For low-income individuals, the cost of…
The post Re-Thinking Management Strateg…


Leveraging affordable innovation to tackle India’s healthcare challenge

This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which presents ways to innovate, be flexible, and do more with…
The post Leveraging affordabl…


New tentative approval for Watson Labs drug dienogest; estradiol valerate

Dienogest; estradiol valerate is the generic ingredient in one branded drug marketed by Bayer Hlthcare and is included in one NDA. There are four patents protecting this compound. This ingredient…
The post New tentative approval for Watson Labs d…


Which pharmaceutical companies have the most drug patents in Luxembourg?

This chart shows the pharmaceutical companies with the most patents in Luxembourg. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most …


A Comparison of Generic Drug Prices in Seven European Countries: A Methodological Analysis

This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research  2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 ©  The Author(s). 2017 Abstract Background Policymakers and researchers frequently com…


Drug Patent Expirations for the Week of November 19, 2017

CIALIS (tadalafil) Lilly Patent: 5,859,006 Expiration: Nov 21, 2017 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post D…


New patent for Abbvie Inc drug MAVYRET

Annual Drug Patent Expirations for MAVYRET Mavyret is a drug marketed by Abbvie Inc and is included in one NDA. It is available from one supplier. The generic ingredient in…
The post New patent for Abbvie Inc drug MAVYRET appeared first on DrugPa…


New patent for Teva Branded drug AUSTEDO

Annual Drug Patent Expirations for AUSTEDO Austedo is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There are four…
The post New patent for Teva Branded drug AUSTEDO appeared first on DrugPat…


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: